GlassScriptPhysician profile
Johanna Bernal
NPI 1669115671
$9,791.89
in general payments reported to CMS, 2019-2025
40 companies · $583 in 2025
The $583 reported for 2025 was more than what 76% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,985 · 2023: $3,621 · 2024: $3,603 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,807.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,640.04 | 2022-2025 | |
| Ucb, INC. | $1,106.94 | 2022-2024 | Briviact, Rystiggo, Nayzilam |
| Novartis Pharmaceuticals Corporation | $716.94 | 2022-2025 | |
| Lilly USA, LLC | $552.46 | 2022-2025 | Amyvid, Emgality, Kisunla |
| Teva Pharmaceuticals USA, INC. | $490.18 | 2022-2024 | Austedo Xr, Austedo |
| Neurocrine Biosciences, INC. | $448.51 | 2023-2024 | Ingrezza, Ongentys |
| Sk Life Science, INC. | $434.63 | 2022-2024 | |
| Mallinckrodt Hospital Products INC. | $362.62 | 2022-2025 | Acthar |
| Pfizer INC. | $318.47 | 2023-2024 | |
| Eisai INC. | $309.97 | 2022-2024 | |
| Argenx US, INC. | $304.48 | 2022-2024 | Vyvgart Hytrulo, Vyvgart |
| Biohaven Pharmaceutical Holding Company LTD. | $290.22 | 2022 | |
| Neurelis, INC. | $247.18 | 2022-2024 | Valtoco |
| Otsuka America Pharmaceutical, INC. | $247.00 | 2023-2024 | Rexulti, Nuedexta |
| Takeda Pharmaceuticals U.S.A., INC. | $213.10 | 2022-2024 | Gammagard, Hyqvia |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $205.17 | 2023-2024 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $180.40 | 2022-2024 | Nuplazid |
| Scilex Pharmaceuticals INC. | $161.88 | 2023 | Ztlido |
| Insulet Corporation | $155.20 | 2025 | Omnipod |
| Tanabe Pharma America, INC. | $133.67 | 2022-2024 | |
| Kyowa Kirin, INC. | $128.75 | 2022-2024 | Nourianz |
| Aprecia Pharmaceuticals, LLC | $128.03 | 2022-2023 | Spritam |
| Amgen INC. | $118.21 | 2024-2025 | Uplizna, Tepezza |
| Amneal Pharmaceuticals LLC | $110.60 | 2023-2024 | Rytary |
| Avion Pharmaceuticals | $103.47 | 2022-2023 | Dhivy |
| Acorda Therapeutics, INC | $98.61 | 2022-2024 | Inbrija, Ampyra |
| Emd Serono, INC. | $87.76 | 2024 | |
| Biogen, INC. | $68.58 | 2023-2024 | Vumerity, Tysabri, Plegridy |
| Corium, LLC | $56.45 | 2023 | Adlarity |
| Csl Behring | $53.67 | 2022-2023 | Hizentra |
| Banner Life Sciences, LLC | $51.35 | 2023-2024 | |
| Tg Therapeutics, INC. | $46.07 | 2024 | |
| Upsher-Smith Laboratories LLC | $45.14 | 2022 | |
| Alexion Pharmaceuticals, INC. | $33.74 | 2023-2024 | Soliris, Ultomiris |
| Mdd US Operations, LLC | $31.99 | 2022 | |
| Vanda Pharmaceuticals INC. | $31.09 | 2023 | Hetlioz, Fanapt |
| Jazz Pharmaceuticals INC. | $21.95 | 2022 | |
| Xeris Pharmaceuticals, INC. | $20.72 | 2025 | Gvoke Hypopen |
| Alfasigma USA, INC. | $18.79 | 2022 | |
| Genzyme Corporation | $17.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johanna Bernal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.